Kotha J - Search Results

1

Engineering colloidally stable, highly fluorescent and nontoxic Cu nanoclusters via reaction parameter optimization.

Busi KB, Kotha J, Bandaru S, Ghantasala JP, Haseena S, Bhamidipati K, Puvvada N, Ravva MK, Thondamal M, Chakrabortty S. Busi KB, et al. Among authors: kotha j. RSC Adv. 2022 Jun 14;12(27):17585-17595. doi: 10.1039/d2ra02819k. eCollection 2022 Jun 7. RSC Adv. 2022. PMID: 35765449 Free PMC article.

2

PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways.

Balamurugan K, Medishetti R, Kotha J, Behera P, Chandra K, Mavuduru VA, Joshi MB, Samineni R, Katika MR, Ball WB, Thondamal M, Challa A, Chatti K, Parsa KVL. Balamurugan K, et al. Among authors: kotha j. iScience. 2022 Jan 12;25(2):103766. doi: 10.1016/j.isci.2022.103766. eCollection 2022 Feb 18. iScience. 2022. PMID: 35141506 Free PMC article.

3

Proband and the Brother.

B S, Kotha JP. B S, et al. Among authors: kotha jp. J Assoc Physicians India. 2023 Jan;71(1):1. J Assoc Physicians India. 2023. PMID: 37116016

4

Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion model.

Bhal V, Herr MJ, Dixon M, Akins S, Hord E, White MM, Seiffert D, Kotha J, Jennings LK. Bhal V, et al. Among authors: kotha j. Thromb Res. 2015 Dec;136(6):1216-23. doi: 10.1016/j.thromres.2015.09.009. Epub 2015 Sep 11. Thromb Res. 2015. PMID: 26412559

5

PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.

Judge HM, Jennings LK, Moliterno DJ, Hord E, Ecob R, Tricoci P, Rorick T, Kotha J, Storey RF. Judge HM, et al. Among authors: kotha j. Platelets. 2015;26(3):236-42. doi: 10.3109/09537104.2014.902924. Epub 2014 Apr 21. Platelets. 2015. PMID: 24750101

6

Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity.

Herr MJ, Longhurst CM, Baker B, Homayouni R, Speich HE, Kotha J, Jennings LK. Herr MJ, et al. Among authors: kotha j. Biochem Biophys Res Commun. 2014 May 16;447(4):616-20. doi: 10.1016/j.bbrc.2014.04.046. Epub 2014 Apr 18. Biochem Biophys Res Commun. 2014. PMID: 24747564

7

The Utility of Platelet and Coagulation Testing of Antithrombotics: Fusing Science with Patient Care.

Jennings LK, Kotha J. Jennings LK, et al. Among authors: kotha j. Drug Dev Res. 2013 Dec;74(8):587-593. doi: 10.1002/ddr.21119. Epub 2013 Nov 15. Drug Dev Res. 2013. PMID: 24489427 Free PMC article.

8

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.

Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Storey RF, et al. Among authors: kotha j. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. Thromb Haemost. 2014. PMID: 24402559 Clinical Trial.

9

Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.

Herr MJ, Kotha J, Hagedorn N, Smith B, Jennings LK. Herr MJ, et al. Among authors: kotha j. PLoS One. 2013 Jun 28;8(6):e67766. doi: 10.1371/journal.pone.0067766. Print 2013. PLoS One. 2013. PMID: 23840773 Free PMC article.

10

Tetraspanins and vascular functions.

Zhang F, Kotha J, Jennings LK, Zhang XA. Zhang F, et al. Among authors: kotha j. Cardiovasc Res. 2009 Jul 1;83(1):7-15. doi: 10.1093/cvr/cvp080. Epub 2009 Feb 27. Cardiovasc Res. 2009. PMID: 19251723 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page